Go back

Biotech industry calls for rethink on genetic technologies

           

“Confused and costly regulation” disadvantages New Zealand, submission on hazardous substances bill says

BioTech New Zealand has called for a “fundamental amendment” to how genetic technologies are regulated in the country.

In a submission on the Hazardous Substances and New Organisms (Hazardous Substances Assessments) Amendment Bill currently before New Zealand’s parliament, the industry body says that “genetic technologies face confused and costly regulation out of step with trading partners”. This is “to the marked disadvantage of New Zealand researchers and commercial businesses alike”, it says.

This article is only available to Research Professional News subscribers. If you are a subscriber you can read the article in full on researchprofessional.com

Pivot-RP users can log in and view the article via this link.